The FDA has significant concerns that performance of the test has not been adequately established, presenting a risk to health.
Home
FDA News Alerts
Stop Using Innova Medical Group SARS-CoV-2 Antigen Rapid Qualitative Test: FDA Safety Communication
Related Posts

Best Brands Consumer Products, Inc. is voluntarily recalling two (2) finished product lots of The Mandalorian Hand Sanitizer Ethyl Alcohol…

Mylan Pharmaceuticals Inc., a Viatris company, is voluntarily recalling one batch of its Insulin Glargine (Insulin glargineyfgn) Injection, 100 units/mL…

The U.S. Food and Drug Administration (FDA) wants to increase awareness about the intended use of imaging software for intracranial…

Today, the FDA issued an emergency use authorization for the first COVID-19 diagnostic test that detects chemical compounds in breath…

FDA issued a final guidance that will help protect animal health by addressing need for access to certain compounded animal…

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. Original source: http://www.fda.gov/news-events/press-announcements/fda-roundup-april-15-2022

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. Original source: http://www.fda.gov/news-events/press-announcements/fda-roundup-april-5-2022

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. Original source: http://www.fda.gov/news-events/press-announcements/fda-roundup-april-1-2022

FDA is announcing it is requesting a total budget of $8.4 billion as part of the President’s fiscal year 2023…

Do not use high-level disinfection methods for reprocessing affected urological endoscopes from Karl Storz. Original source: http://www.fda.gov/medical-devices/letters-health-care-providers/update-change-reprocessing-methods-certain-karl-storz-urological-endoscopes-letter-health-care